Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
Cellular and stromal components including tumor cells, immune cells, mesenchymal cells, cancer-linked fibroblasts, and extracellular matrix, constituent tumor microenvironment (TME). TME plays a crucial role in reprogramming tumor initiation, uncontrolled proliferation, invasion and metastasis as well as response to therapeutic modalities. In recent years targeting the TME has developed as a potential strategy for treatment of cancer because of its life-threatening functions in restricting tumor development and modulating responses to standard-of-care medicines. Cold atmospheric plasma, oncolytic viral therapy, bacterial therapy, nano-vaccine, and repurposed pharmaceuticals with combination therapy, antiangiogenic drugs, and immunotherapies are among the most effective therapies directed by TME that have either been clinically authorized or are currently being studied. This article discusses above-mentioned therapies in light of targeting TME. We also cover problems related to the TME-targeted therapies, as well as future insights and practical uses in this rapidly growing field.
Plasmonic Nanomedicine Coupled Biomolecular Fingerprinting of Brain Cancer
Science Foundation IrelandFind out more...
PublicationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023, 1869 (6), 166746
Also affiliated with
- Bernal Institute
Sustainable development goals
- (3) Good Health and Well-being
Department or School